VRDN-003, Next-Generation Full Antagonist Monoclonal Antibody to IGF-1R: Two Randomized Placebo-Controlled Clinical Studies in Patients With TED (REVEAL-1 and REVEAL-2). American Society of Ophthalmic Plastic and Reconstructive Surgery 55th Annual Fall Scientific Symposium October 2024.